Torrent Pharma has recently begun to plot an upmove on the back of continuous buying. We take you through the chart, indicating long and short term stop-losses and potential appreciation.
[videopress lAxwaYBS loop="true" autoplay="true"]
Disclaimer:
We, Ventura Securities Ltd, (SEBI Registration Number INH000001634) its Analysts & Associates with regard to blog article/video hereby solemnly declare & disclose that:
We do not have any financial interest of any nature in the company.
We do not individually or collectively hold 1% or more of the securities of the company.
We do not have any other material conflict of interest in the company.
We do not act as a market maker in securities of the company.
We do not have any directorships or other material relationships with the company.
We do not have any personal interests in the securities of the company.
We do not have any past significant relationships with the company such as Investment Banking or other advisory assignments or intermediary relationships.
We are not responsible for the risk associated with the investment/disinvestment decision made on the basis of this blog article/video.

What is price to book ratio & how it helps you select equity stocks
4 min Read Sep 12, 2023
12 Effective Options Trading Strategies you should know
9 min Read Sep 6, 2023
How PE valuation can help you time your stock investment
4 min Read Sep 2, 2023
LIC IPO may recreate the Maruti moment of 2003 for markets: Nilesh Shah
4 min Read Feb 21, 2022
Nippon India Pharma Fund: On a firm footing
5 min Read Jul 7, 2021
Revisiting the Gold-Silver Ratio Amid Silver's Outperformance
< 1 min Read Dec 22, 2025
Midcaps: Sweet Spot or Danger Zone? | What HSBC MF’s Cheenu Gupta Thinks | Ventura Spotlight
< 1 min Read Dec 17, 2025
Understanding Option Pin risk near expiry
< 1 min Read Dec 12, 2025
EPS in the Stock Market
< 1 min Read Dec 12, 2025
What is stagflation?
< 1 min Read Dec 10, 2025
Post your comment
You must be logged in to post a comment.